A bold plan to restore affordability, innovation, and integrity to the American healthcare system.
Joined July 2025
- Tweets447
- Following33
- Followers110
- Likes1
Pinned Tweet
Our scorecard illustrates how countries like the UK, France, Germany, & Japan pay too little for innovative medicines, leaving American patients to carry a disproportionate share of drug development costs. @kerpen @SteveForbesCEO @StephenMoore
Learn more: mostfavoredpatient.org/resou…
Most Favored Patient retweeted
Watch our new ad: Bernie Sanders’ Medicare for All scheme will throw senior citizens over the cliff and bankrupt Medicare.
70 Million seniors will lose their Medicare.
Ask your Senator and Rep: Do you support Medicare for All?
Most Favored Patient retweeted
Medicare for All is deceptive wordplay.
The Democrats' single-payer bill BANS Medicare Advantage and traditional Medicare and dumps every senior into the same system with every US resident, including illegal aliens.
Calling their UK-style system "Medicare" is just a cover to confuse seniors. This plan destroys Medicare.
Most Favored Patient retweeted
Countries like France, Germany, and Japan maintain drug price controls that hamper U.S. biopharma innovation, lowering access to innovative treatments and leaving American patients with higher prices. @MFPatient's new scorecard details more. @Comm4Prosperity
committeetounleashprosperity…
Most Favored Patient retweeted
The new @MFPatient scorecard identifies countries that have not ended foreign freeloading and highlights how low spending on drugs in the UK, France, Germany, and Japan discourages investment and limits patients' access to new treatments. @Comm4Prosperity
committeetounleashprosperity…
Most Favored Patient retweeted
While the UK "agreed to pay more for US brand drugs, other nations, including France, Germany, and Japan, are doubling down on socialist-style price controls," says @Comm4Prosperity.
See how this impacts patient drug access in @MFPatient's new scorecard. committeetounleashprosperity…
New in @Comm4Prosperity Hotline: When foreign countries stop freeloading, they also win. "As the scorecard shows, price controls come with a lack of access to the latest, greatest medicine. When you pay more, you get more." @StephenMoore @kerpen @SteveForbesCEO committeetounleashprosperity…
Medicare for all is Medicare for nobody. Instead of providing more coverage, this plan would bankrupt Medicare, putting health care coverage at risk for patients across the country. Americans need more access, not less. @Comm4Prosperity @StephenMoore
hannity.com/media-room/hands…
Most Favored Patient retweeted
Foreign freeloading is creating larger barriers for seniors to access innovative medicines & treatments. @MFPatient's new scorecard with @Comm4Prosperity tracks how some countries are answering @POTUS's call to end the free-riding. @kerpen
Check it out: mostfavoredpatient.org/inter…
Most Favored Patient retweeted
NEW: @MFPatient scorecard reveals which countries have answered @POTUS' call to end foreign freeloading on American innovation.
Through trade negotiations, the US has made a deal with the UK to put patients first. Germany, Japan, and France have not yet done so.
See the full scorecard: mostfavoredpatient.org/inter…
JUST IN: Ahead of midterms, MFP released a new scorecard that tracks and ranks foreign countries on drug pricing, patient access, and whether each has answered @POTUS's call to end foreign freeloading. @Comm4Prosperity
Read the press release here:
mostfavoredpatient.org/resou…
COINS was built to keep US money out of China’s military tech. Stretching it to cover #Rx investment is a terrible idea. Cutting off these deals won’t stop breakthroughs. It just hands them to Chinese companies. Read more in MFP's recent statement on the extension. @kerpen @USTreasury mostfavoredpatient.org/resou…
Really, @AARPadvocates? Rising premiums, deductibles & copays are older Americans' top health care concern, yet 0 questions in @AARP poll. Wake up! AARP is paid BILLION$ via insurer-PBM UnitedHealth (under DOJ investigation). How’s this ok? @kerpen @costplusdrugs @Statnews @WSJopinion
IRA drug price "negotiations" are really price controls that distort market signals and inhibit development of new medicines. "Bringing a new drug to market can cost upwards of $2 billion. If the likelihood of recouping that investment shrinks, so too does the motivation to innovate." @NRO
nationalreview.com/2026/10/b…
“As the world's largest market for pharmaceuticals, America finds itself in the unique position of accruing the lion's share of the benefits from new medicines. We often recoup these additional costs in the form of longer and healthier lives,” says @USCSchaeffer's Dana Goldman. Importing foreign drug price controls will threaten these lifesaving benefits.
realclearmarkets.com/article…
America is the global leader of medical innovation, but not by accident. It is the result of deliberate policy choices that reward innovation, and it has delivered breakthrough treatments for patients.
China is rapidly gaining ground on the U.S. We must say no to price controls that would further cede leadership to them. @RepBenCline
washingtontimes.com/news/202…
Patients are already paying too much for health care. Now big insurers like @UHC are raising out-of-pocket costs, cutting benefits and narrowing access to doctors and hospitals.
Enough. Congress needs to rein in insurers and put patients first. @bobjherman @statnews statnews.com/2026/10/01/medi…
Importing Europe’s price controls with Most Favored Nation pricing will not fix U.S. healthcare costs. @SenateGOP & @HouseGOP "should instead focus on a reform that is already reducing patients' prices: direct-to-consumer (DTC) pharmaceutical sales." More:
realclearhealth.com/articles…
Tying U.S. drug prices to foreign price controls through Most Favored Nation could "threaten jobs, undermine manufacturing investment and weaken U.S. drugmakers' ability to compete with China." Patients need free-market solutions. @kerpen @FoxNewsOpinion
foxnews.com/opinion/trump-lo…
